丹特罗是一种HDL相关的偏氧酶-1激活剂,具有免疫抑制和动脉保护性质

Anastasia-Georgia Dedemadi1, Eirini Sevdali2, Daphne Georgiadou3

  • 1Institute of Biosciences and Applications, National Center for Scientific Research "Demokritos", Agia Paraskevi, Athens, Greece; Department of Chemistry, National and Kapodistrian University of Athens, Zografou, Athens, Greece.

概括

丹特烯增强了偏氧酶1 (PON1) 活性,改善了高密度脂蛋白 (HDL) 的功能. 这种药物通过调节免疫细胞反应来减少小鼠关节炎的严重程度,这表明它有可能治疗动脉样硬化.